no news_id given

Tech Review


The market share of ultrafast sequencing machines on the total sequencing market is set to expand rapidly. In April 2010, Roche daughter 454 Life Sciences (Branford, US) is launching a new system especially designed for...

Tech Review


Luxembourg has appeared from nowhere with an initiative to set up a European center for diagnostic biomarkers, while it’s government has set aside EUR140m to reach some ambitious goals. To speed up development, Luxembourg looked...

Tech Review


Systems biology is aimed at achieving a holistic understanding of living organisms, while synthetic biology seeks to design and construct new living organisms with targeted functionalities. Genome sequencing and the fields of...

Politics / Law


Europe is to receive a new Super Commissioner for biotech, as well as the largest budget for research the bloc has ever granted. Even before the start of hearings considering the 26 Commission nominees that began in mid-January,...



The new EU Commissioner-Delegate for Health and Consumer Policy made his case to the European Parliament in January, and has now been granted a revamped portfolio of previously distinct health-related organisations and...



Reykjavik – Iceland's deCode Genetics has reimmerged as a private biotechnology company following its purchase from its former parent company by Saga Investments LLC, a consortium that includes Polaris Ventures and ARCH Venture...

Politics / Law


Darmstadt/Berlin – Cultivation of GM maize in the EU fell sharply in 2009, according to figures from The most active country is still Spain, which makes up more than 80% of all GM cultivation. In 2009, European...

Politics / Law, GermanyGermany


Germany has launched Europe’s first civil high-throughput screening facility for high-risk infectious agents within the framework of ERA-NET PathoGenoMics. The novel bio-safety level 3 (BSL3) unit at the Max Planck Institute for...

Politics / Law


Brussels/Strasbourg – John Dalli, the designated Super Commissioner for Biotechnology has set out his future priorities as Health Commissioner of the European Commission. In a document published on 23 December by the European...

Displaying results 351 to 360 out of 1983

< Previous 351-360 Next >

© 2007-2015 BIOCOM


All videos

Product of the week



LentiKat’s offers an unusual investment opportunity

LentiKat’s owns, manufactures and distributes a patented immobilization into lentil-shaped Lentikats Biocatalysts. The unique lentil-like shape of the Lentikats Biocatalyst ensures unlimited diffusion of substrate(s) into any part of the matrix, while still retaining a convenient size for easy separation from the reaction medium. They find application in the Pharma & Food industry (including bio-based chemicals), Wastewater treatment as well as Biofuels. more...


All Events



BioVaria 2015

Job Advert

Sales Manager

celares GmbH is a Berlin based drug delivery company focused on chemical modifications of biological drugs. We offer customized development services for international pharma and biopharma companies and have manufacturing capabilities for key starting materials used for the preparation of pharmaceutical drugs. For the intensification of our own sales activities we are looking for a sales manager. more...

Stock list

All quotes


  • WILEX3.59 EUR5.59%
  • BASILEA118.10 CHF3.14%
  • PAION2.58 EUR2.79%


  • BIOTEST79.20 EUR-19.51%
  • CYTOS1.01 CHF-8.18%
  • FORMYCON28.00 EUR-6.01%


  • CO.DON3.15 EUR22.1%
  • WILEX3.59 EUR21.3%
  • FORMYCON28.00 EUR21.0%


  • CYTOS1.01 CHF-27.9%
  • BIOTEST79.20 EUR-18.1%
  • THERAMETRICS0.07 CHF-12.5%


  • SANTHERA98.85 CHF2460.9%
  • CYTOS1.01 CHF676.9%
  • WILEX3.59 EUR337.8%


  • MOLOGEN5.07 EUR-54.8%
  • THERAMETRICS0.07 CHF-30.0%
  • BIOFRONTERA2.41 EUR-28.1%

No liability assumed, Date: 26.04.2015

Current issue

All issues